Copyright
©The Author(s) 2018.
World J Gastroenterol. Oct 21, 2018; 24(39): 4489-4498
Published online Oct 21, 2018. doi: 10.3748/wjg.v24.i39.4489
Published online Oct 21, 2018. doi: 10.3748/wjg.v24.i39.4489
Table 3 Laboratory tests pre and post-intervention
| Pre-intervention | 2 wk after intervention | t | P value | |
| ALT (U/L) | 98.93 ± 24.47 | 36.13 ± 8.99 | 10.41 | < 0.001 |
| TBIL (μmol/L) | 39.40 ± 7.76 | 21.47 ± 12.09 | 6.52 | < 0.001 |
| Amylase (U/L) | 80.73 ± 14.94 | 82.07 ± 17.77 | 0.34 | 0.741 |
| WBC (× 109/L) | 11.58 ± 1.45 | 7.65 ± 2.11 | 5.90 | < 0.001 |
| HGB (g/L) | 122.93 ± 8.66 | 118.80 ± 13.39 | 1.52 | 0.150 |
- Citation: Chang HY, Wang CJ, Liu B, Wang YZ, Wang WJ, Wang W, Li D, Li YL. Ursodeoxycholic acid combined with percutaneous transhepatic balloon dilation for management of gallstones after elimination of common bile duct stones. World J Gastroenterol 2018; 24(39): 4489-4498
- URL: https://www.wjgnet.com/1007-9327/full/v24/i39/4489.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i39.4489